NC-182 is a novel antitumor agent applicable to both multidrug-resistant and sensitive tumors; it functions as a potent DNA intercalator, stabilizing the DNA double helix and triplex structures, and inducing conformational transitions in DNA (e.g., B- to non-B-form and Z- to B-form), which contributes to its biological activity.